|
thrombin-activatable fibrinolysis inhibitor
thrombin-activated platelets
thrombin-antithrombin complex
thrombin receptor
thrombin time
thrombocythemia
thrombocytopenia
thrombocytopenic patients
thrombocytopenic purpura
thromboembolic complications
thromboembolic disease
thromboembolic disorders
thromboembolic events
|
thromboembolic pulmonary hypertension
thromboembolic risk
thromboembolism
thromboembolism prophylaxis
thrombolysis
thrombolytic agents
thrombolytic therapy
thrombolytic treatment
thrombophilia
thrombophilic abnormalities
thrombophilic defects
thrombophilic factors
thromboplastin time
thrombopoietin levels
|
thromboprophylaxis
thrombosis
thrombosis model
thrombosis prophylaxis
thrombospondin motifs
thrombotic complications
thrombotic disease
thrombotic episode
thrombotic events
thrombotic microangiopathy
thrombotic occlusion
thrombotic responses
thrombotic risk
thrombotic tendency
|
thrombotic thrombocytopenic purpura
thromboxane A2 mimetic
thromboxane A2 receptor
thromboxane B2
thromboxane synthase inhibitor
thrombus
thrombus burden
thrombus formation
thrombus weight
throughput
throughput analysis
throughput performance
throughput screening
throughput technologies
|
throw light
thrust
thrust belt
thrust fault
thrust front
thrust propagation
thrust sheets
thrust system
|
